Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...
Pharvaris advances an oral bradykinin B2 franchise with late-stage HAE programs, strong data, and major catalysts. Learn why ...
Inflammatory biomarkers in ischemic stroke: mechanisms, clinical applications, and future directions
Ischemic stroke is a complex cerebrovascular disorder characterized by highly unpredictable outcomes influenced by ...
At interim analysis, giredestrant demonstrated a statistically significant and clinically meaningful benefit versus ...
Cellular death within the infarcted core occurs rapidly due to energy depletion, resulting in the release of DAMPs such as ...
Polish diagnostician Dr. Jaroslaw Wilczynski says to look beyond symptoms, analyze the data and admit where things go wrong ...
Zymeworks Inc., a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...
Chemerin is a key adipokine that regulates lipid metabolism and insulin sensitivity, and thus is involved in many metabolic ...
Sixty-four years after the first female contraceptive pill was approved for NHS use in the UK, science is finally on the ...
Roche (OTCQX:RHHBY) unit Genentech announced on Tuesday that giredestrant, a selective estrogen receptor degrader (SERD), ...
New research shows that the same dopamine receptor mechanism responsible for drug addiction also governs the natural decline in motivation when we repeat rewarding behaviors.
New research indicates that mitochondrial dysfunction triggers a cascade of cellular changes that drive Parkinson’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback